Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Unknown 2Recruiting 2Completed 2Terminated 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2Thoracic 1Other solid neoplasm 1Genitourinary 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Small Cell Lung Carcinoma 2Neoplasms 2Head and Neck Neoplasms 2Gastrointestinal Neoplasms 2Colorectal Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Merkel Cell 2Breast Neoplasms 2Urinary Bladder Neoplasms 1Turcot syndrome 1Stomach Neoplasms 1Sarcoma 1Penile Neoplasms 1PD-L1 Positive Mutation Tumor 1Non-Muscle Invasive Bladder Neoplasms 1Neoplasm Metastasis 1Mesothelioma, Malignant 1Melanoma 1Lymphoma, Extranodal NK-T-Cell 1Leukemia, Myeloid, Chronic-Phase 1Hodgkin Disease 1Hemangiosarcoma 1Glioblastoma 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Endometrial Neoplasms 1Colonic Neoplasms 1Carcinoma, Hepatocellular 1Carcinoma 1

Interventions

Cisplatin 28Radiotherapy 20pembrolizumab 9Paclitaxel 9Surveys and Questionnaires 8Cetuximab 8Fluorouracil 7Docetaxel 7Radiotherapy, Intensity-Modulated 6Carboplatin 6apatinib 5Low-Level Light Therapy 5Blood Specimen Collection 5durvalumab 4Standard of Care 4Magnetic Resonance Imaging 4Gemcitabine 4Cyclophosphamide 4Celecoxib 4Tegafur 3Radiation 3Oncolytic Virotherapy 3Nivolumab 3Magnetic Resonance Spectroscopy 3Lidocaine 3Immunoenzyme Techniques 3Drug Therapy 3Chemotherapy, Adjuvant 3Biopsy 3toripalimab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Head and Neck Neoplasms × avelumab × Clear all
NCT05429866 2023-03-08

Immunological Variables Associated to ICI Toxicity in Cancer Patients

Jules Bordet Institute

Phase 2 Unknown
441 enrolled
BreastDermatologicGastrointestinalGenitourinaryHead & NeckOther solid neoplasmThoracic

Mesothelioma, Malignant, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Melanoma, Carcinoma, Merkel Cell, Small Cell Lung Carcinoma

NCT03844763 2020-03-03

CONFRONT

Gruppo Oncologico del Nord-Ovest

Phase 1/2 Unknown
71 enrolled
Head & Neck

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡